NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Clorox stock soars to 52-week high, reaches $169.09

Published 11/18/2024, 03:55 PM
CLX
-

In a remarkable display of resilience, Clorox Co (NYSE: NYSE:CLX) stock has surged to a 52-week high, touching a price level of $169.09. This peak comes amidst a challenging economic landscape, signaling strong investor confidence in the company's performance and future prospects. Over the past year, Clorox has seen its value increase by an impressive 21.44%, outpacing many competitors in the consumer goods sector. The company's ability to achieve such a significant milestone in its stock price reflects a robust business model and a solid commitment to growth, even as markets worldwide face uncertainty and volatility.

In other recent news, Clorox has been the subject of several analyst reports following a strong first quarter of fiscal year 2025. The company outperformed expectations with a significant earnings per share beat and a robust 31% growth in organic sales, as reported by DA Davidson and Jefferies. This performance comes after a full recovery from a cyberattack that affected the previous year's quarter. In response, DA Davidson increased Clorox's price target from $153 to $171 and maintained a Neutral rating, while Jefferies raised the share price target slightly to $188 from $187 and maintained a Buy rating.

TD Cowen also upgraded Clorox from Sell to Hold, citing a conservative fiscal year 2025 guidance by the company and a stronger recovery following the cyber-attack incident. The firm increased the price target to $170 from $155, indicating a shift in the company's outlook. Clorox's management is seen as having the flexibility to deliver more earnings per share beats and upward revisions, leading to a more favorable performance for the company's shares in the near term.

Despite projecting a low-teens sales decrease for the second quarter due to volume pull-forward, Clorox anticipates organic growth to be between 3% to 5% in the latter half of the year. The company's promotional environment has returned to pre-COVID levels, with strategic promotional spending planned. These are recent developments that reflect the company's resilience and strategic positioning in the market.

InvestingPro Insights

Clorox's recent stock performance aligns with several key metrics and insights from InvestingPro. The company's stock is currently trading near its 52-week high, with a price that is 99.72% of its highest point over the past year. This bullish trend is further supported by InvestingPro data showing a strong 25.63% price total return over the last six months.

InvestingPro Tips highlight Clorox's commitment to shareholder value, noting that the company has raised its dividend for 48 consecutive years and has maintained dividend payments for 54 consecutive years. This consistent dividend policy likely contributes to investor confidence and the stock's recent rally.

While the stock's current P/E ratio of 58.59 might seem high, it's worth noting that InvestingPro Tips suggest Clorox is trading at a low P/E ratio relative to near-term earnings growth. This could indicate potential for further stock appreciation if the company meets growth expectations.

For investors seeking more comprehensive analysis, InvestingPro offers 11 additional tips for Clorox, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.